Fig. 3.
Representation of the influence of different pretreatment regimens in SCID and NOD-SCID mice on the survival and spreading of transplanted Hu-PBL, on human immunoglobulin production, on the life span of the transplanted animals, on the severity of graft-versus-host disease (GVHD) and on the necessity of a booster dose for antigen-specific immunoglobulin production.